BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · IEX Real-Time Price · USD

1.810

+0.030 (1.69%)

At close: May 31, 2024, 4:00 PM

1.860

+0.050 (2.76%)

After-hours: May 31, 2024, 7:57 PM EDT

BioXcel Therapeutics Market Cap

BioXcel Therapeutics has a market cap or net worth of $67.93 million as of May 31, 2024. Its market cap has decreased by -91.02% in one year.

Market Cap

67.93M

Enterprise Value

95.77M

1-Year Change

-91.02%

Ranking

#4375

Market Cap Chart

Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $167.60M to $67.93M, a decrease of -59.47%. That is a compound annual growth rate of -13.48%.

Market Cap History

Date	Market Cap	% Change
May 31, 2024	67.90M	1.65%
May 30, 2024	66.80M	-0.60%
May 29, 2024	67.20M	-3.72%
May 28, 2024	69.80M	-
May 24, 2024	69.80M	0.58%
May 23, 2024	69.40M	-6.09%
May 22, 2024	73.90M	-1.99%
May 21, 2024	75.40M	-4.31%
May 20, 2024	78.80M	1.42%
May 17, 2024	77.70M	-0.89%
May 16, 2024	78.40M	1.42%
May 15, 2024	77.30M	-3.25%
May 14, 2024	79.90M	-2.56%
May 13, 2024	82.00M	4.59%
May 10, 2024	78.40M	-9.36%
May 9, 2024	86.50M	33.49%
May 8, 2024	64.80M	-9.87%
May 7, 2024	71.90M	-6.26%
May 6, 2024	76.70M	-2.42%
May 3, 2024	78.60M	0.38%
May 2, 2024	78.30M	0.77%
May 1, 2024	77.70M	0.78%
Apr 30, 2024	77.10M	-2.28%
Apr 29, 2024	78.90M	-1.87%
Apr 26, 2024	80.40M	0.75%

View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Personalis	68.04M
Lantern Pharma	67.78M
Intensity Therapeutics	67.74M
Annovis Bio	67.03M
Pro-Dex	67.01M
Dyadic International	66.37M
Rallybio	65.90M
CEL-SCI	65.53M

Market Cap Rankings